CLINICAL_TRIALS
trial_result
· 2012-12-24
Clinical Trial Update: Phase I Study in RAD 001 Patients With Relapse AML [Phase 1]
Summary
Phase I study of RAD 001 (ridaforolimus) in patients with relapsed acute myeloid leukemia has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: French Innovative Leukemia Organisation | Conditions: AML | Phase 1 | Status: COMPLETED